Morgan Stanley
DRTS icon

Morgan Stanley’s Alpha Tau Medical DRTS Stock Holding History

Morgan Stanley’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$173K Buy
24,471
+5,358
+28% +$37.8K ﹤0.01% 5933
2025
Q4 		$94.6K Sell
19,113
-30,895
-62% -$130K ﹤0.01% 6227
2025
Q3 		$226K Buy
50,008
+11,458
+30% +$39K ﹤0.01% 5850
2025
Q2 		$120K Sell
38,550
-4,791
-11% -$13.5K ﹤0.01% 6067
2025
Q1 		$109K Buy
43,341
+390
+0.9% +$1.22K ﹤0.01% 5967
2024
Q4 		$133K Sell
42,951
-390
-0.9% -$998 ﹤0.01% 5940
2024
Q3 		$103K Hold
43,341
– – ﹤0.01% 5998
2024
Q2 		$110K Sell
43,341
-265,241
-86% -$675K ﹤0.01% 5929
2024
Q1 		$910K Sell
308,582
-301,782
-49% -$927K ﹤0.01% 5006
2023
Q4 		$1.84M Buy
610,364
+570,061
+1,414% +$1.84M ﹤0.01% 4969
2023
Q3 		$153K Hold
40,303
– – ﹤0.01% 5700
2023
Q2 		$176K Buy
40,303
+21,700
+117% +$77.8K ﹤0.01% 5700
2023
Q1 		$53.4K Hold
18,603
– – ﹤0.01% 6263
2022
Q4 		$59.2K Buy
18,603
+7,020
+61% +$29K ﹤0.01% 6218
2022
Q3 		$67K Sell
11,583
-6,922
-37% -$61.1K ﹤0.01% 6265
2022
Q2 		$167K Buy
18,505
+11,655
+170% +$104K ﹤0.01% 5983
2022
Q1 		$81K Buy
+6,850
New +$80.5K ﹤0.01% 6452

Other funds holding DRTS

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $130M AUM
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

Morgan Stanley's DRTS Position: Q1 2026 in Review

Morgan Stanley increased its Alpha Tau Medical (DRTS) stake by 28% in Q1 2026, buying an estimated $37.8K and bringing the position to 24,471 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #5933.

Morgan Stanley first reported a position in DRTS in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.84M in Q4 2023. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

  • Morgan Stanley held 24,471 shares of Alpha Tau Medical worth $173K as of Q1 2026.
  • Morgan Stanley bought 5,358 Alpha Tau Medical shares in Q1 2026, an estimated $37.8K.
  • Alpha Tau Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #5933 holding.
  • Morgan Stanley first reported a position in Alpha Tau Medical in Q1 2022 and has held it in 17 quarters since.
  • Morgan Stanley's Alpha Tau Medical position peaked at $1.84M in Q4 2023.
  • 53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.